Abrdn Global Equity Impact Fund OCSE:NSIS B Holdings History
abrdn Focused Emerging Markets ex-China Fund's Novonesis (Novozymes) B Holding Summary
As of 2025-04-30, abrdn Focused Emerging Markets ex-China Fund held - shares of Novonesis (Novozymes) B(OCSE:NSIS B), totaling N/A. This investment constitutes 0% of their stock portfolio, and abrdn Focused Emerging Markets ex-China Fund now holds 0% of the outstanding Novonesis (Novozymes) B(OCSE:NSIS B) stock.
The initial trade took place in 2025Q1. And since then abrdn Focused Emerging Markets ex-China Fund has made 1 purchases of OCSE:NSIS B, at an average price of kr411.26, for a total of 8,300.00 shares. In addition, there have been 1 sales at an average price of kr408.03 for 8,300.00 shares. Based on historical transaction data and OCSE:NSIS B's current price of kr451.00, abrdn Focused Emerging Markets ex-China Fund's estimated gain on his OCSE:NSIS B holdings is kr-26,809.00, reflecting a -0.79% gain to date.
abrdn Focused Emerging Markets ex-China Fund OCSE:NSIS B (kr451.00) Holding Chart
abrdn Focused Emerging Markets ex-China Fund OCSE:NSIS B (kr451.00) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
